Concepedia

How to optimize hepatitis C virus treatment impact on life years saved in resource‐constrained countries

Dorothée Obach, Yazdan Yazdanpanah, Gamal Esmat, Anchalee Avihingsanon, Sahar Dewedar, Nicolas Durier, Alain Attia, Wagida A. Anwar, Anthony Cousien, Pisit Tangkijvanich,

Hepatology · 2015 · 26 citations · 18 references

DOI

Abstract

Our model-based analysis demonstrates that prioritizing treatment in F3-F4 patients in resource-constrained countries is the most effective scenario in terms of LYS, regardless of treatment considered.

References

18

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

Eric Lawitz, Alessandra Mangia, David Wyles et al. · New England Journal of Medicine · 2013 · 1.8K citations

Evolving epidemiology of hepatitis C virus

Daniel Lavanchy · Clinical Microbiology and Infection · 2010 · 1.3K citations · Full text

, , +6

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

Christina Frank, Mostafa K. Mohamed, G. Thomas Strickland et al. · The Lancet · 2000 · 1.1K citations

, , +7

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

Gary L. Davis, Miriam J. Alter, Hashem B. El‐Serag et al. · Gastroenterology · 2009 · 881 citations · Full text

, , +13

Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C

Edward Gane, Catherine Stedman, Robert H. Hyland et al. · New England Journal of Medicine · 2013 · 754 citations · Full text